National Australia Bank Ltd
ASX:NAB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.19
44.67
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
NAB
stock under the Base Case scenario is
36.907
AUD.
Compared to the current market price of 42.125 AUD,
National Australia Bank Ltd
is
Overvalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for National Australia Bank Ltd.
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
|
| ZA |
C
|
Capitec Bank Holdings Ltd
JSE:CPI
|
|
| ZA |
S
|
Standard Bank Group Ltd
JSE:SBK
|
|
| CN |
|
Agricultural Bank of China Ltd
SSE:601288
|
|
| CN |
|
Industrial and Commercial Bank of China Ltd
SSE:601398
|
|
| US |
|
Bank of America Corp
NYSE:BAC
|
|
| CN |
|
China Construction Bank Corp
SSE:601939
|
|
| US |
|
Wells Fargo & Co
NYSE:WFC
|
|
| UK |
|
HSBC Holdings PLC
LSE:HSBA
|
|
| CN |
|
Bank of China Ltd
SSE:601988
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
NAB’s substantial exposure to Australian SMEs could become a liability if rising interest rates and subdued economic growth increase loan defaults, pressuring the bank’s asset quality and profitability.
Intensifying competition from non-traditional lending platforms and fintech disruptors may erode NAB’s market share, making it more challenging to defend net interest margins and attract customers.
Regulatory scrutiny, stemming from the Royal Commission findings and ongoing compliance risks, could require higher capital buffers or additional remediation costs, widening the gap between expenses and revenue growth.
NAB delivers a robust commercial banking franchise with a leading presence in small and medium-sized enterprise lending, positioning the bank to capture outsized growth when business confidence rebounds.
Ongoing improvements in customer experience, driven by digital initiatives like NAB’s transformation program and enhanced digital platforms, are poised to solidify brand loyalty and optimize operating efficiency.
Strong capital ratios and a conservative balance sheet should enable NAB to weather cyclical downturns more effectively than competitors, supporting steady dividends and long-term stability for shareholders.
Balance Sheet Decomposition
National Australia Bank Ltd
| Net Loans | 776.1B |
| Investments | 248.2B |
| PP&E | 2.7B |
| Intangibles | 5.6B |
| Other Assets | 76.4B |
| Total Deposits | 748.5B |
| Short Term Debt | 4.8B |
| Long Term Debt | 185.2B |
| Other Liabilities | 107.6B |
Wall St
Price Targets
NAB Price Targets Summary
National Australia Bank Ltd
According to Wall Street analysts, the average 1-year price target for
NAB
is 37.45 AUD
with a low forecast of 29.29 AUD and a high forecast of 48.468 AUD.
Dividends
Current shareholder yield for
NAB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NAB
stock under the Base Case scenario is
36.907
AUD.
Compared to the current market price of 42.125 AUD,
National Australia Bank Ltd
is
Overvalued by 12%.